Prof. Diana Gorog, Consultant Cardiologist
Prof. Diana Gorog
Consultant Cardiologist
Prof. Diana Gorog MB, MS, FRCP, MD, PhD, FESC
Consultant Cardiologist
Prof. Diana Gorog
Consultant Cardiologist MB, MS, FRCP, MD, PhD, FESC
Prof. Gorog is a recommended Consultant Cardiologist
Areas of expertise
- Acute coronary syndrome (ACS)
- Angina
- Arrhythmia (irregular heartbeat)
- Atherosclerosis
- Atrial fibrillation
Recommendations for Prof. Gorog
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
by Mr Dan Wood, Consultant Urologist
❝Recommended cardiologist❞
by Mr Dan Wood, Consultant Urologist
❝Recommended cardiologist❞
Make an appointment
Address
-
The Harley Street Clinic HCA
35 Weymouth Street, London, W1G 8BJ
About Prof. Diana Gorog
GMC number: 4034982
Year qualified: 1993
Place of primary qualification: University of London
Areas of expertise
- Cardiology
- Arrhythmia
- Atrial fibrillation
- Coronary artery disease
- Echocardiography
- Hypertension
- Interventional cardiology
- Vascular medicine
Professional memberships
Articles by Prof. Diana Gorog
Non-vitamin k antagonist oral anticoagulants versus warfarin for patients with left ventricular thrombus: a systematic review and meta-analysis
Role, laboratory assessment and clinical relevance of fibrin, factor xiii and endogenous fibrinolysis in arterial and venous thrombosis
Prevalence of thrombotic complications in icu-treated patients with coronavirus disease 2019 detected with systematic ct scanning
Ethnic difference of thrombogenicity in patients with cardiovascular disease: a pandora box to explain prognostic differences
Thrombotic complications in 2,928 patients with covid-19 treated in intensive care: a systematic review
Assessment of endogenous fibrinolysis in clinical using novel tests - ready for clinical roll-out?
Out-of-hospital cardiac arrest: a systematic review of current risk scores to predict survival
Endogenous fibrinolysis - relevance to clinical thrombosis risk assessment
Antithrombotic therapy in diabetes: which, when 1 and for how long?
Precision treatment in acs – role of assessing fibrinolysis
